We willhaveexclusivityAn actualiMSCupdateHemorrhoidsis a $2BmarketWe will openupinternationalsites forMino-Lok trialI/ONTAK'spotentialmarket is>$300mNot manycompaniesthis size with2 late stageassetsWe expect tofinish theMino-Loktrial this yearI'm ashareholdermyselfAnymentionof Mino-WrapThe name Citiuscomes from theOlympic motto"Citius,AltiusForius"Our Halo-Lido trial willhave finalpatient byend of 2022Only biotechwith 2 Myron'son theleadershipteamInsidersinvested$26.5mI won't diluteshareholdersI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.We haveenough cashto go wellinto 2023There are noFDAapproveddrugs to treathemorrhoidsWe intendto submita BLA in2H 2022We had aphase 2btrial with100%efficacyI/ONTAKis our leadassetMyron Holubiakand I founded aprivatecompany in2013Mino-Lokpotentialmarket>$1BI/ONTAKwas thebest deal Iever madeMino-Lokis our leadassetWe willhaveexclusivityAn actualiMSCupdateHemorrhoidsis a $2BmarketWe will openupinternationalsites forMino-Lok trialI/ONTAK'spotentialmarket is>$300mNot manycompaniesthis size with2 late stageassetsWe expect tofinish theMino-Loktrial this yearI'm ashareholdermyselfAnymentionof Mino-WrapThe name Citiuscomes from theOlympic motto"Citius,AltiusForius"Our Halo-Lido trial willhave finalpatient byend of 2022Only biotechwith 2 Myron'son theleadershipteamInsidersinvested$26.5mI won't diluteshareholdersI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.We haveenough cashto go wellinto 2023There are noFDAapproveddrugs to treathemorrhoidsWe intendto submita BLA in2H 2022We had aphase 2btrial with100%efficacyI/ONTAKis our leadassetMyron Holubiakand I founded aprivatecompany in2013Mino-Lokpotentialmarket>$1BI/ONTAKwas thebest deal Iever madeMino-Lokis our leadasset

Leonard Mazur HCW Conference BINGO - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. We will have exclusivity
  2. An actual iMSC update
  3. Hemorrhoids is a $2B market
  4. We will open up international sites for Mino-Lok trial
  5. I/ONTAK's potential market is >$300m
  6. Not many companies this size with 2 late stage assets
  7. We expect to finish the Mino-Lok trial this year
  8. I'm a shareholder myself
  9. Any mention of Mino-Wrap
  10. The name Citius comes from the Olympic motto "Citius,Altius Forius"
  11. Our Halo-Lido trial will have final patient by end of 2022
  12. Only biotech with 2 Myron's on the leadership team
  13. Insiders invested $26.5m
  14. I won't dilute shareholders
  15. I/ONTAK was previously approved but taken off the market to improve manufacturing.
  16. We have enough cash to go well into 2023
  17. There are no FDA approved drugs to treat hemorrhoids
  18. We intend to submit a BLA in 2H 2022
  19. We had a phase 2b trial with 100% efficacy
  20. I/ONTAK is our lead asset
  21. Myron Holubiak and I founded a private company in 2013
  22. Mino-Lok potential market >$1B
  23. I/ONTAK was the best deal I ever made
  24. Mino-Lok is our lead asset